Thalidomide

E3 Ligase: Thalidomide recruits cereblon (CRBN) as its E3 ligase, leveraging CRBN’s substrate-binding domain to facilitate selective ubiquitination of neosubstrate proteins. This recruitment is central to its molecular glue activity.

Target Protein: Thalidomide primarily targets IKZF1 and IKZF3, transcription factors critical for lymphoid cell development. By engaging these proteins, it promotes their recognition by the CRBN E3 ligase complex.

Degradation Mechanism: Thalidomide mediates proteasomal degradation through the ubiquitin–proteasome system. Formation of the CRBN–IKZF1/3 ternary complex promotes polyubiquitination, leading to recognition and clearance by the 26S proteasome, resulting in efficient depletion of the target proteins in cells.

• Molecular Glue Functionality: Thalidomide acts as a molecular glue by promoting the interaction between cereblon, a substrate receptor of the E3 ubiquitin ligase complex, and specific target proteins. This interaction leads to the ubiquitination and subsequent degradation of the target proteins, providing a powerful tool for researchers investigating protein homeostasis and degradation pathways.

• Targeted Degradation of Transcription Factors: Thalidomide is instrumental in the targeted degradation of transcription factors such as Ikaros and Aiolos. By facilitating their ubiquitination via cereblon, researchers can study the downstream effects on gene expression and cellular differentiation, offering insights into hematological malignancies and immune responses.

• Protein Degradation Mechanism Studies: As a prototype molecular glue, Thalidomide enables the exploration of the mechanistic aspects of protein degradation. By elucidating how Thalidomide alters substrate specificity of cereblon, scientists can design novel molecules for targeted protein degradation, advancing therapeutic strategies for diseases associated with protein accumulation.

• Modulation of Immune Responses: Through its molecular glue properties, Thalidomide aids in the degradation of proteins involved in immune regulation. This application is crucial for researchers examining the modulation of immune responses, particularly in the context of inflammatory diseases and autoimmune disorders, by targeting specific protein pathways.